Pharmaceutical Raw Materials Female Steroids Raw Hormone Powders Mifepristone CAS 84371-65-3
Pharmaceutical Raw Materials Female Steroids Raw Hormone Powders Mifepristone CAS 84371-65-3
Basic Info.
Mifepristone
CAS Number: 84371-65-3
Molecular Formula: C29H35NO2
Molecular Weight: 429.65
Melting Point: 195-198 Degree C
Appearance: Light yellowish powder
Use: Used for a variety of allergic skin diseases and cosmetic additives
Packing: 1kg/aluminum foil bag
Assay: 99%
Standard: Enterprise Standard
Used: raw material powder
Packing: 1kg/aluminum foil bag
Description:
Mifepristone is a synthetic steroid compound with both antiprogesterone and antiglucocorticoid properties. The compound is a 19-nor steroid with substitutions at positions C11 and C17 (17 beta-hydroxy-11 beta-[4-dimethylamino phenyl] 17 alpha-[1-propynyl]estra-4, 9-dien-3-one), which antagonizes cortisol action competitively at the receptor level.
Mifepristone is a progesterone receptor antagonist used as an abortifacient in the first months of pregnancy, and in smaller doses as an emergency contraceptive. It is also a powerful glucocorticoid receptor antagonist.
Applications:
Mifepristone is used alone or in combination with misoprostol (Cytotec) to end an early pregnancy. Early pregnancy means it has been 49 days or less since your last menstrual period began. Mifepristone is in a class of medications called antiprogestational steroids. It works by blocking the activity of progesterone, a substance your body makes to help continue pregnancy.
Mifepristone is also available as another product (Korlym), which is used to control hyperglycemia (high blood sugar) in people with a certain type of Cushing's Syndrome in which the body makes too much of the hormone cortisol. This monograph only gives information about mifepristone (Mifeprex), which is used alone or in combination with another medication to end an early pregnancy. If you are using mifepristone to control hyperglycemia caused by Cushing's syndrome, read the monograph entitled mifepristone (Korlym) that has been written about this product.
Mifepristone (or RU-486) is a synthetic steroid compound with both antiprogesterone and antiglucocorticoid properties. The compound is a 19-nor steroid with substitutions at positions C11 and C17 (17 beta-hydroxy-11 beta-[4-dimethylamino phenyl] 17 alpha-[1-propynyl]estra-4, 9-dien-3-one), which antagonizes cortisol action competitively at the receptor level.
Mifepristone is a progesterone receptor antagonist used as an abortifacient in the first months of pregnancy, and in smaller doses as an emergency contraceptive. It is also a powerful glucocorticoid receptor antagonist, and has occasionally been used in refractory Cushing's syndrome (due to ectopic/neoplastic ACTH/cortisol secretion).
Mifepristone was the first antiprogestin to be developed and it has been evaluated extensively for its use as an abortifacient.
Send product request
Other supplier products
| Testosterone Phenylpropionate Injectable Steroids for Muscle Building | Testosterone Phenylpropionate Injectable Steroids for Muscle Building Basic Infor: Testosterone Phenylpropionate Product name : Testosterone Phe... | |
| 99% Pharmaceutical Sarms Powder Ostarine Enobosarm Mk-2866 | 99% Pharmaceutical Sarms Powder Ostarine Enobosarm Mk-2866 Basic Info: Product Name: MK-2866, Ostarine CAS: MF: C19H14F3N3O3 MW: 389.3279696 P... | |
| Pharma Antiviral Agents Tenofovir Disoproxil Fumarate CAS for Medicine Ingredients | Pharma Antiviral Agents Tenofovir Disoproxil Fumarate CAS for Medicine Ingredients Basic info: Tenofovir CAS: MF: C9H14N5O4P MW:287.21 mp:276-... | |
| 99% High Purity Male Hormone Raw Anabolic Trenbolone Steroids 3704-09-4 Mibolerone | 99% High Purity Male Hormone Raw Anabolic Trenbolone Steroids 3704-09-4 Mibolerone Basic Info. Product Name: Mibolerone CAS: 3704-09-4 MF: C20H3... | |
| 99% High Purity Prohormones Steroids Raw Powder Estriol CAS 50-27-1 | 99% High Purity Prohormones Steroids Raw Powder Estriol CAS 50-27-1 Basic Info. Estriol Synonyms: 50-27-1, steroid powder, Estriol CAS No.: 50-2... |
















